Partial neuromuscular blockade to facilitate lung and diaphragm protective mechanical ventilation in ICU patients. A randomized controlled pilot study.
Phase of Trial: Phase IV
Latest Information Update: 16 Nov 2018
Price : $35 *
At a glance
- Drugs Rocuronium bromide (Primary)
- Indications Muscle hypertonia; Neuromuscular blockade
- Focus Adverse reactions; Therapeutic Use
- 02 Nov 2018 Status changed from not yet recruiting to recruiting.
- 20 Aug 2018 New trial record